Outcome Markers for Clinical Trials in Cerebral Amyloid Angiopathy

The Lancet Neurology - United Kingdom
doi 10.1016/s1474-4422(14)70003-1
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Elsevier BV

Related search

Superficial Siderosis in Cerebral Amyloid Angiopathy

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2009English

Cerebral Amyloid Angiopathy Impact on Endothelium

Experimental Gerontology
AgingGeneticsCell BiologyMolecular BiologyBiochemistryEndocrinology
2012English

Apolipoprotein D: A Potential Biomarker for Cerebral Amyloid Angiopathy

Neuropathology and Applied Neurobiology
Forensic MedicinePathologyNeurologyHistologyPhysiology
2020English

Surgical Risk of Hemorrhage in Cerebral Amyloid Angiopathy

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1991English

Cerebral Amyloid Angiopathy: A Common Cause of Cerebral Hemorrhage

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2009English

Pleiotropic Neuroprotective Effects of Taxifolin in Cerebral Amyloid Angiopathy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Erratum: Evidence for Human Transmission of Amyloid-Β Pathology and Cerebral Amyloid Angiopathy

Nature
Multidisciplinary
2015English

Predictors of Localization, Outcome, and Etiology of Spontaneous Intracerebral Hemorrhages: Focus on Cerebral Amyloid Angiopathy

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2020English

Impaired Visual Evoked Flow Velocity Response in Cerebral Amyloid Angiopathy

Neurology
Neurology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy